NCT02111473

The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism

Phase 4 Study of Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 49 (actual)
• Sponsor: Gulhane School of Medicine · Academic / Other
• Sex: Male
• Age: 18 Years – 28 Years
• Healthy volunteers: Not accepted

Summary

The study is designed to answer the following questions: 1\) What is the effect of testosteron replacement treatment on the endothelial dysfunction. 2/ What is the effect of testosteron replacement on the bone mineral metabolism.

Detailed description

this is an interventional study which is examine the effect of testosteron replacement treatment on the endothelial dysfunction and bone mineral metabolism in hypogonadotropic hypogonadal patients.

Conditions

• Hypogonadism

Interventions

Type	Name	Description
DRUG	Testosterone	Testosterone 250 mg injection per 3-4 weeks for 6 months

Timeline

• Start date: 2009-05-01
• Primary completion: 2012-05-01
• Completion: 2014-04-01
• First posted: 2014-04-11
• Last updated: 2014-04-11

Locations

1 site across 1 country: Turkey (Türkiye)